Apotex Health Corp faces a challenging trading day as its stock slips significantly.
Apotex Health Corp (APTX.TO) is seeing a decline in its stock price, with shares dropping by 1.21% to close at CA$32.75. This dip comes despite recent corporate developments that haven’t yet boosted investor confidence.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.34B
52W high
$40.18
52W low
$26.05
1W change
-1.28%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 24.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+24.7% Upside
Current Price
C$33.15
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
41.1%
Annualized
90-Day Vol
48.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$39.63
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$35.18 | C$30.53 – C$40.54 |
| 60 trading days | C$37.34 | C$30.56 – C$45.63 |
| 90 trading days | C$39.63 | C$31.01 – C$50.66 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Even with recent revenue growth and strategic initiatives, Apotex's stock is struggling to gain traction, indicating potential concerns among investors.
1.21% Decline in Stock Price
Apotex's stock fell by 1.21% today, reflecting investor hesitation despite positive developments in recent months.
Bull case
Apotex has demonstrated promising revenue growth and formed strategic partnerships. If managed well, these factors could set the company up for future success.
Bear case
The recent drop in stock price raises doubts about investor confidence and whether the company can effectively leverage its recent achievements.
Recent Performance Overview
Advertisement
Apotex Health Corp's stock has declined by 1.21% today, closing at CA$32.75. This drop follows a series of positive announcements about revenue growth and strategic partnerships, suggesting that investor sentiment may not fully reflect the company’s recent successes. The market cap is around CA$7.54 billion, showing significant investor interest despite current challenges.
Investor Sentiment and Market Reaction
The recent downturn in Apotex's stock price might reflect broader market concerns or specific worries from investors about the company’s ability to maintain its growth. While Apotex reported an 11% revenue growth in its first quarter of 2027, the negative price movement indicates that investors are cautious. For more insights on Apotex's performance, check out our detailed analysis on APTX.TO.
Looking Ahead
As Apotex Health Corp navigates its current challenges, investors will be closely watching for any further developments that could impact stock performance. Recent strategic moves, including its listing on the Toronto Stock Exchange and Health Canada's approval for SEVMIA™, could significantly influence future investor confidence. For more information about Apotex's market position, visit our page on APTX.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
